Plugging gaps in China's hepatitis B prevention would be cost effective

BMJ ◽  
2009 ◽  
Vol 339 (oct28 2) ◽  
pp. b4420-b4420
Author(s):  
J. Parry
Keyword(s):  
Hepatitis B ◽  
Cost Effective ◽  
Hepatitis B Prevention

Hepatitis B Vaccination of Personnel Employed in Victorian Hospitals: Are Those at Risk Adequately Protected?

1999 ◽  
Vol 20 (01) ◽  
pp. 51-54 ◽  
Author(s):  
Sandra C. Thompson ◽  
Maureen Norris
Keyword(s):  
Hepatitis B ◽  
Cost Effective ◽  
Healthcare Personnel ◽  
Hepatitis B Vaccination ◽  
Hepatitis B Infection ◽  
Prevention Policy ◽  
Primary Series ◽  
Job Title ◽  
Rural Institutions ◽  
Hepatitis B Prevention

AbstractObjective:To examine the policies and practices in hospitals within the state of Victoria, Australia, with respect to vaccination of staff against hepatitis B infection.Design:A written self-administered questionnaire to be completed by the infection control officer (or designated officer for hepatitis B vaccination) within each hospital.Setting:Public (teaching and nonteaching) and private hospitals, including metropolitan and rural institutions in Victoria.Participants:A random sample of 30% of Victorian hospitals were asked to participate in the survey. Of 78 eligible institutions, 69 (88%) completed and returned questionnaires.Results:There was no consistent hepatitis B prevention policy in place across Victoria. Of the 69 responding hospitals, 63 (91%) offered hepatitis B vaccination to staff, and 58 (84%) of these also paid all costs of vaccination. Of the 63 hospitals offering vaccination to staff, 39 offered vaccination to all staff, 23 offered vaccination based on job title, and one offered vaccination based on anticipated exposure. In many institutions, postexposure protocols were recalled more readily than preexposure vaccination guidelines. Numerous respondents indicated a need for clear guidelines on policy and clarification on practical matters of management, such as acceptable immune levels, management of nonresponders to the primary series, and the need for, and timing of, booster doses of vaccine. Eleven (18%) of the 63 hospitals offering hepatitis B vaccination to staff undertook routine prevaccination screening, a practice not generally regarded as cost-effective in Australia. Fifty-five of these hospitals (91%) also undertook postvaccination screening.Conclusions:It is evident from this study that a considerable number of potentially susceptible healthcare personnel in Victorian hospitals remain unprotected against hepatitis B infection. A more reliable and consistent approach to preexposure hepatitis B vaccination is recommended

Hepatitis B Prevention: Practices and Attitudes of Physicians and Dentists

1986 ◽  
Vol 2 (5) ◽  
pp. 290-296
Author(s):  
Kenneth E. Sherman ◽  
Susan N. Sherman ◽  
William P. Ku ◽  
Barbara Stewart ◽  
Gail J. Povar
Keyword(s):  
Hepatitis B ◽  
Hepatitis B Prevention

scholarly journals Contribution of HIV/AIDS-Related Human and Social Sciences Research to a Better Understanding of the Challenges of Hepatitis B Prevention, Diagnosis and Care

2021 ◽  
Vol 9 (6) ◽  
pp. 1166
Author(s):  
Charlotte Bauquier ◽  
Marie Préau
Keyword(s):  
Social Sciences ◽  
Hepatitis B ◽  
Retention In Care ◽  
World Health ◽  
Public Health Issue ◽  
Human And Social Sciences ◽  
Virus Research ◽  
Screening And Prevention ◽  
Hepatitis B Prevention ◽  
Hiv Aids

Recent scientific advances in hepatitis B virus research hint at the possibility of finding a cure in the medium term. In this context, the characterization of infected persons constitutes a major public health issue in terms of implementing adapted screening and prevention strategies. Overcoming the current challenges national health systems face in hepatitis B diagnosis is essential if the World Health Organization’s target of treating 80% of infected patients by 2030 is to be reached. These challenges reflect those previously faced in the fight against HIV/AIDS. Using the knowledge produced to date in Human and Social Sciences research in the fight against HIV/AIDS, we propose avenues of reflection to support and guide the development of research in the diagnosis of hepatitis B infection. More specifically, we present theoretical, methodological and epistemological considerations for how HSS research can be optimized in the following three HBV diagnosis-related areas: (i) access to screening; (ii) retention in care; and (iii) the integration of quality of life measurement in clinical trials.

Torres Strait Islanders‘ understandings of chronic hepatitis B and attitudes to treatment

2016 ◽  
Vol 22 (4) ◽  
pp. 316 ◽  
Author(s):  
Elayne Anderson ◽  
Jeanne Ellard ◽  
Jack Wallace
Keyword(s):  
Chronic Hepatitis ◽  
Liver Cancer ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Cost Effective ◽  
Cancer Surveillance ◽  
Indigenous Australians ◽  
Remote Communities ◽  
Torres Strait

Indigenous Australians are disproportionally affected by hepatitis B compared with non-Indigenous Australians. The higher prevalence of hepatitis B among Indigenous Australians has been linked to an increased incidence of liver cancer in this population. There is evidence that comprehensive programs of hepatitis B virus management, which include liver cancer surveillance and appropriate antiviral therapy, offer a cost-effective approach to reduce the incidence of liver cancer in Australia. This paper reports on data from the first study investigating understandings of hepatitis B and attitudes to treatment among Torres Strait Islanders living with chronic hepatitis B. Forty-two participants completed an interview questionnaire. Participants typically had an unclear understanding of hepatitis B and reported significant gaps in monitoring and follow up. A majority of participants indicated a willingness to use treatment if required. The findings of this study suggest the need for a new service delivery model that is appropriate to remote communities such as the Torres Strait Islands, to improve hepatitis B follow up, disease monitoring and management, and where appropriate, the uptake of treatment.

Infection Control and Employee Health Hepatitis B Prevention Part 1 A Review of AC IP's Newest Guidelines

1986 ◽  
Vol 7 (2) ◽  
pp. 74-77 ◽  
Author(s):  
William M. Valenti
Keyword(s):  
Hepatitis B ◽  
Infection Control ◽  
Employee Health ◽  
Control Programs ◽  
The Past ◽  
B Virus ◽  
Important Trend ◽  
Fluid Process ◽  
Hepatitis B Screening ◽  
Hepatitis B Prevention

Since the introduction of hepatitis B immune globulin (HBIg) and more recently, the hepatitis B vaccine, programs for hepatitis B prevention have become a major part of most employee health/infection control programs. In fact, hepatitis B prevention activities have probably been responsible for increased collaboration between the two programs. Hepatitis B prevention is a very fluid process and is constantly changing as we develop a greater understanding of the creative uses of both HBIg and the vaccine. On e important trend that has emerged from the introduction and widespread use of HBIg and vaccine has been a greater emphasis on pre-exposure prevention of hepatitis B infection. In the past, programs for hepatitis B prevention consisted of periodic hepatitis B screening in dialysis units and some laboratories. Unfortunately, screening only monitors introduction of infection and does very little to prevent hepatitis B virus (HBV) infection.

Sign in / Sign up

Export Citation Format

Share Document